Oct 8, 2026 | Blog
A cancer trial can have an approved protocol, a trained team and medicine ready to dispense, yet remain out of reach for a patient waiting for a pathology result. Before an investigator can assess eligibility, someone must obtain an adequate sample, establish the...
Oct 1, 2026 | Blog
In 2019, the CREOLE trial addressed a practical question: which combinations of commonly used medicines lowered blood pressure most effectively in Black African patients with uncontrolled hypertension? Conducted in six sub-Saharan African countries, the study found...
Sep 24, 2026 | Blog
Four days after Uganda confirmed an outbreak of Sudan virus disease in January 2025, a clinical trial evaluating a candidate vaccine was launched. Investigators from Makerere University and the Uganda Virus Research Institute worked with the Ministry of Health, the...
Sep 17, 2026 | Blog
A completed trial that never reports its results does not disappear quietly. Participants still took the risk. The site still did the work. The funding was still spent. What disappears is the evidence, and with it the only public record that any of it was done...
Sep 10, 2026 | Blog
A clinical trial closes. Its samples and data may still have years of scientific life ahead. Stored specimens can support new investigations. Trial datasets can help researchers answer questions beyond the original protocol. Further analysis may contribute to a...
Sep 3, 2026 | Blog
A clinical trial conducted in Africa may recruit African participants, rely on African investigators and address a pressing African health need, yet still route its funding, protocol design, data governance and publication decisions through institutions thousands of...
